John G Ullman & Associates Inc. Sells 9,273 Shares of Azenta, Inc. (NASDAQ:AZTA)

John G Ullman & Associates Inc. decreased its stake in Azenta, Inc. (NASDAQ:AZTA - Free Report) by 8.3% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 102,552 shares of the company's stock after selling 9,273 shares during the period. John G Ullman & Associates Inc. owned 0.22% of Azenta worth $3,552,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of the stock. Farther Finance Advisors LLC raised its position in Azenta by 788.1% during the 1st quarter. Farther Finance Advisors LLC now owns 968 shares of the company's stock worth $33,000 after buying an additional 859 shares during the last quarter. Headlands Technologies LLC acquired a new stake in Azenta in the 4th quarter valued at about $40,000. Covestor Ltd boosted its stake in shares of Azenta by 64.2% during the 4th quarter. Covestor Ltd now owns 2,043 shares of the company's stock worth $102,000 after purchasing an additional 799 shares during the last quarter. Quarry LP acquired a new stake in shares of Azenta during the 4th quarter worth about $110,000. Finally, Sterling Capital Management LLC boosted its stake in shares of Azenta by 39.8% during the 4th quarter. Sterling Capital Management LLC now owns 2,856 shares of the company's stock worth $143,000 after purchasing an additional 813 shares during the last quarter. Institutional investors and hedge funds own 99.08% of the company's stock.

Azenta Stock Performance

Shares of AZTA traded up $0.47 during midday trading on Friday, hitting $34.43. 437,863 shares of the stock traded hands, compared to its average volume of 952,662. Azenta, Inc. has a 1-year low of $23.91 and a 1-year high of $63.58. The firm has a market capitalization of $1.58 billion, a PE ratio of -24.77 and a beta of 1.64. The business's 50 day moving average price is $30.35 and its two-hundred day moving average price is $35.93.

Azenta (NASDAQ:AZTA - Get Free Report) last posted its quarterly earnings data on Wednesday, May 7th. The company reported $0.05 earnings per share for the quarter, missing the consensus estimate of $0.09 by ($0.04). Azenta had a positive return on equity of 1.30% and a negative net margin of 10.31%. Azenta's quarterly revenue was up 5.1% compared to the same quarter last year. During the same quarter last year, the company posted $0.06 earnings per share. As a group, equities research analysts forecast that Azenta, Inc. will post 0.53 EPS for the current fiscal year.

Analyst Ratings Changes

AZTA has been the topic of several research analyst reports. Evercore ISI raised their target price on shares of Azenta from $29.00 to $35.00 and gave the stock an "in-line" rating in a research report on Tuesday, July 8th. Needham & Company LLC cut their price target on shares of Azenta from $59.00 to $40.00 and set a "buy" rating on the stock in a report on Wednesday, May 7th. Finally, Stephens started coverage on shares of Azenta in a report on Tuesday. They issued an "equal weight" rating and a $35.00 price target on the stock.

About Azenta

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.